Ready to play
Ready to play
A 19-year-old British student used the weight-loss medication Terzibatid inside her university dormitory in London, leading to severe arrhythmia and her sudden death. Investigations revealed that the student had experienced symptoms of vomiting and nausea before her death, and that the drug—used for managing diabetes and also for weight loss—caused an electrolyte imbalance in her body, resulting in a deadly cardiac disturbance. The investigations recommend that weight-loss medications should only be taken under medical supervision, especially for individuals with heart conditions or cardiac defects, to avoid similar fatal risks.
Notice: This Is an AI-Generated Summary
Comments (0)